the aid library

LIST OPTIONS

Filter

4913

Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032

World Health Organization WHO (2022) C_WHO

The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, a... more

Download (134)

View PDF (158)

Tuberculosis in the Americas. Regional Report 2020

Pan American Health Organisation PAHO (2021) C_WHO

This regional report on the situation of tuberculosis (TB) in the Americas contains information from 2019, provided by the countries of the Region through the World Health Organization TB data collection system. These data have been consolidated and analyzed at the regional level. In addition to pre... more

External Link

Climate Solutions Double as Health Interventions

Mailloux, N.A. et al. (2021) CC

Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339 The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and vector-borne infectious diseases, and... more

Download (142)

View PDF (161)

ACT-Accelerator Transition Plan (1 Oct 2022 to 31 Mar 2023)

World Health Organization WHO (2022) C_WHO

31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.   Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co... more

Download (230)

View PDF (223)

Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region

World Health Organization WHO WHO Regional Office for the Eastern Mediterranean (2014) CC

This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ... more

Download (248)

View PDF (223)

Addressing violence against women in health policies and protocols in the Americas: A regional status report

World Health Organisation (WHO) (2023) C_WHO

Violence against women and girls is widespread in the Region of the Americas, resulting in enormous consequences for the health and wellbeing of women and girls, their families and communities. These costs are unacceptable and they can be prevented through evidence-based action, including the health... more

Download (140)

View PDF (144)

Public Spending on Health: A Closer Look at Global Trends

World Health Organisation (WHO) (2018) C_WHO

The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T... more

Download (166)

View PDF (272)

Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia Region to support universal health coverage

World Health Organisation (WHO) (2023) C_WHO

Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ... more

Download (285)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (224)

View PDF (183)

WHO benchmarks for strengthening health emergency capacities
recommended

World Health Organization WHO (2024) C_WHO

Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a... more

Health equity for persons with disabilities: guide for action
recommended

World Health Organisation (WHO) (2024) C_WHO

An estimated 1.3 billion people globally experience significant disability. This figure has grown over the last decade and will continue to rise due to demographic and epidemiological changes. In 2022, the World Health Organization launched the Global report on health equity for persons with disabil... more

External Link

КАРМАННЫЙ СПРАВОЧНИК Оказание стационарной помощи детям

Всемирная организация здравоохранения (ВОЗ) (2013) C_WHO

РУКОВОДСТВО ПО ВЕДЕНИЮ НАИБОЛЕЕ РАСПРОСТРАНЕННЫХ БОЛЕЗНЕЙ ДЕТСКОГО ВОЗРАСТА Второе издание Данная публикация является вторым изданием Карманного справочника... more

Download (439)

View PDF (1285)

Protecting, promoting, and supporting breastfeeding in facilities providing maternity and newborn services: the revised Baby-friendly Hospital Initiative 2018 Implementation guidance

World Health Organization, UNICEF (2018) C_WHO

This updated implementation guidance is intended for all those who set policy for, or offer care to, pregnant women, families and infants: governments; national managers of maternal and child health programmes in general, and of breastfeeding- and BFHI-related programmes in particular; and health-f... more

Download (247)

View PDF (356)

Rwanda: MATERNAL, NEONATAL AND CHILD HEALTH NATIONAL STRATEGY JULY 2013- JUNE 2018

Ministry of Health, Rwanda & Rwanda Biomedical Centre (2013) C2

This document sets out Rwanda's Maternal, Neonatal Child Health (MNCH) national strategy (July 2013- June 2018). The MNCH strategy provides a framework for addressing maternal, neonatal and child health challenges currently facing Rwanda. It is an overarching strategy for scale up of the national re... more

External Link

The Sphere Handbook. Humanitarian Charter and Minimum Standards in Humanitarian Response. New Edition
recommended

Sphere (2018) C1

Humanitarian Charter and Minimum Standards in Humanitarian Response. The 2018 Sphere Handbook builds on the latest developments and learning in the humanitarian sector. Among the improvements of the new edition, readers will find a stronger focus on the role of local authorities and communities as ... more

Download (326)

View PDF (734)

Joint Response Plan for Rohingya Humanitarian Crisis January- December 2019
recommended

Strategic Executive Group and Partners United Nations and Partners (2019) C1

The Joint Response Plan sets out a comprehensive programme shaped around three strategic objectives – deliver protection, provide life-saving assistance and foster social cohesion. The Plan covers all humanitarian sectors and addresses key cross-cutting issues, including protection and gender main... more

Emergency Use Designation of COVID-19 candidate vaccines: Ethical considerations for current and future COVID-19 placebo-controlled vaccine trials and trial unblinding

World Health Organization WHO (2020) C_WHO

The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... more

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended

World Health Organization WHO (2021) C_WHO

2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati... more

Download (121)

View PDF (170)

Toward Harmonization: Community Health Policy and Program Trends

USAID, JSI Research & Training Institute, fhi360 (2020) CC

The Community Health Systems (CHS) Catalog is a resource that provides information on community health program workers, and interventions for the 25 countries deemed priority by USAID’s Of of Population and Reproductive Health. It comprises a compilation of 25 country profiles developed from a de... more

Download (405)

View PDF (481)

South African MATERNAL, PERINATAL, and NEONATAL Health Policy

National Department of Health (NDoH) South Africa NDoH South Africa (2021) CC

As a lower-middle-income country (LMIC), South Africa (SA) bears the burden of maternal and neonatal mortality similar to other sub- Saharan African countries. According to the Saving Mothers Report 2017/19, there has been a progressive and sustained reduction in institutional maternal mortality... more

WHO benchmarks for strengthening health emergency capacities recommended

Health equity for persons with disabilities: guide for action recommended

The Sphere Handbook. Humanitarian Charter and Minimum Standards in Humanitarian Response. New Edition recommended

Joint Response Plan for Rohingya Humanitarian Crisis January- December 2019 recommended

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention recommended

WHO benchmarks for strengthening health emergency capacities
recommended

Health equity for persons with disabilities: guide for action
recommended

The Sphere Handbook. Humanitarian Charter and Minimum Standards in Humanitarian Response. New Edition
recommended

Joint Response Plan for Rohingya Humanitarian Crisis January- December 2019
recommended

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended